Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.
All content for Cleveland Clinic Cancer Advances is the property of Cleveland Clinic Taussig Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.
Breathing New Life Into Cancer Treatment: Inhaled KB707
Cleveland Clinic Cancer Advances
17 minutes
3 months ago
Breathing New Life Into Cancer Treatment: Inhaled KB707
Wen Wee Ma, MBBS, Enterprise Vice Chair for Research and Director of the Novel Cancer Therapeutics Center, joins the Cancer Advances Podcast to discuss a phase 1 trial of KB707 presented at ASCO 2025. This innovative therapy delivers IL-2 and IL-12 directly to the lungs through inhalation, aiming to minimize side effects and improve outcomes for patients with lung tumors. Dr. Ma shares early trial results and what they could mean for the future of cancer treatment.
Cleveland Clinic Cancer Advances
Urologic Oncologist at Cleveland Clinic Weston Hospital, Alberto Pieretti, MD, joins the Cancer Advances Podcast to talk about how innovations in imaging, biomarkers and multidisciplinary care are reshaping the diagnosis and management of prostate cancer. Hear how advances such as PSMA PET scans, biomarker-guided biopsies and precision therapies are improving outcomes and quality of life for patients.
